Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide for PTSD
NCT04378426Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nitrous oxide in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Oct 2021; status: terminated.
02
Drugs
nitrous oxide
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04378426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04378426.